Comparing of INSYS Therapeutics Inc. (INSY) and uniQure NV (NASDAQ:QURE)

As Biotechnology companies, INSYS Therapeutics Inc. (NASDAQ:INSY) and uniQure N.V. (NASDAQ:QURE) are our subject to contrast. And more specifically their risk, analyst recommendations, profitability, dividends, earnings and valuation, institutional ownership.

Valuation and Earnings

Demonstrates INSYS Therapeutics Inc. and uniQure N.V. earnings per share (EPS), top-line revenue and valuation.

Profitability

Table 2 shows us the return on equity, return on assets and net margins of both companies.

Risk Volatility

A 2.56 beta indicates that INSYS Therapeutics Inc. is 156.00% more volatile compared to SP 500. From a competition point of view, uniQure N.V. has a 1.07 beta which is 7.00% more volatile compared to SP 500.

Liquidity

The current Quick Ratio of INSYS Therapeutics Inc. is 0.6 while its Current Ratio is 0.7. Meanwhile, uniQure N.V. has a Current Ratio of 7.6 while its Quick Ratio is 7.6. uniQure N.V. is better positioned to pay off its

... read more at: https://portcourier.com/2019/03/17/comparing-of-insys-therapeutics-inc-insy-and-uniqure-n-v-nasdaqqure/

by